Andrzej Hellmann

7.2k citations
58 papers · 3.1k · 2 hit papers · h-index 24

Impact in

  • Genetics top 0.2%
    • Chronic Lymphocytic Leukemia Research
  • Hematology top 0.5%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
    • Platelet Disorders and Treatments

Papers in

    • Chronic Lymphocytic Leukemia Research 37
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 4
    • Chronic Myeloid Leukemia Treatments 12
    • Acute Myeloid Leukemia Research 9

Andrzej Hellmann

56 papers receiving 3.0k citations

Andrzej Hellmann's Hit Papers

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome 2018 · 356 citations
3560+2+5Years since publication100200300

Peers

Andrzej Hellmann
Comparison fields: 5 of 78
  • Genetics 1.6k
  • Hematology 1.4k
  • Pathology and Forensic Medicine 1.1k
  • Immunology 596
  • Oncology 497
Replace Monica Bocchia with:
Monica Bocchia Italy
Stefan Faderl United States
Farrukh T. Awan United States
Preetesh Jain United States
Marı́a Rozman Spain
David Westerman Australia
Carolyn Owen Canada
Françoise Rigal‐Huguet France
H. Kantarjian United States
Thomas J. Nevill Canada
Andrzej Hellmann relative to Monica Bocchia Italy Monica Bocchia's profile →
Citations per field
00.5×2.6×
Monica Bocchia · 1×
Citations per year

Countries citing papers authored by Andrzej Hellmann

Since Specialization
Citations

This map shows the geographic impact of Andrzej Hellmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Hellmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Hellmann more than expected).

Fields of papers citing papers by Andrzej Hellmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrzej Hellmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Hellmann. The network helps show where Andrzej Hellmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrzej Hellmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrzej Hellmann Line = papers co-authored together Andrzej Hellmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2010414
2
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
Hit paper breakdown →
2018356
3 2007287
4 2007278
5
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials
Hit paper breakdown →
2018243
6 2011204
7 2008203
8 2000185
9 2018106
10 201071
11 202167
12 200355
13 199650
14 200346
15 200244
16 201343
17 199741
18 200534
19 201631
20 201130

About Andrzej Hellmann

Andrzej Hellmann is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Immunology and Molecular Biology, having authored 58 papers that have together received 3.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (37 papers), Lymphoma Diagnosis and Treatment (18 papers), Chronic Myeloid Leukemia Treatments (12 papers), Immunodeficiency and Autoimmune Disorders (11 papers), Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (5 papers), Eosinophilic Disorders and Syndromes (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Genetics (1.6k citations), Hematology (1.4k citations), Pathology and Forensic Medicine (1.1k citations), Immunology (596 citations) and Oncology (497 citations). Andrzej Hellmann has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Tadeusz Robak, Jerzy Hołowiecki, Geoffrey Chan, Jan Walewski, Jiřı́ Mayer, Lars Møller Pedersen, Jørgen Holm Petersen, Mimi Folden Flensburg, Nedjad Losic and Ole Gadeberg. Their work appears in journals such as Blood, Journal of Clinical Oncology, European Journal Of Haematology, British Journal of Haematology and Journal of Cancer Research and Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact